Toho University is a university in Ōta, Tokyo, Japan.

During the past decade, Toho University School of Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toho University School of Medicine" #1 sponsor was "Japan Rhabdomyosarcoma Study Group" with 2 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Ophthalmic PDT Study Group" with 1 trials sponsored and "Taewoong Medical Co., Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toho University School of Medicine" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Bard Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Toho University School of Medicine" are "Colorectal Cancer" (2 trials), "Sarcoma" (2 trials), "Age Related Macular Degeneration" (1 trials), "Cancer of Bile Duct" (1 trials) and "Critical Limb Ischemia" (1 trials). Many other conditions were trialed in "Toho University School of Medicine" in a lesser frequency.

Most popular intervention types in "Toho University School of Medicine" are "Drug" (4 trials), "Biological" (2 trials), "Device" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "cyclophosphamide" (2 trials), "dactinomycin" (2 trials), "vincristine sulfate" (2 trials) and "Lutonix DCB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toho University School of Medicine" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Toho University School of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Toho University School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toho University School of Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Toho University School of Medicine has several departments that took part in Clinical trials: "Toho University Sakura Medical Center" - 34 trials